There have been about a quarter fewer opioid-related overdose deaths in D.C. in the first half of this year, and new data ...

Opioid use is more prevalent among individuals with vs without IBD, although not related to a psychiatric comorbidity.

Kitsap had not reported a quarter-over-quarter decline in overdoses in more than 2 years, according to the health district.

Opioid antagonists are medications people can take to treat opioid use disorder. They help by reducing withdrawal symptoms, addressing cravings, and managing overdoses. Doctors prescribe opioid ...

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Corp. with ...

Purdue Pharma has completed the first phase of a study examining the use of nalmefene hydrochloride (HCI) injection in real-world emergency department (ED) settings. Researchers are now conducting ...

with a label expansion into other pain settings coming after an initial approval in that indication. Vertex Pharma has filed for FDA approval of its non-opioid pain drug suzetrigine, starting the ...

For years, fentanyl has become an increasingly ominous part of the U.S. drug trade – a powerful and cheap synthetic opioid ...

Kentucky’s attorney general is suing the pharmacy benefit manager (PBM) Express Scripts over its role in “worsening” the state’s opioid crisis. In the complaint filed in state court ...

ALT5 Sigma Corporation (NASDAQ:ALTS) (”ALT5” or the “Company”), a fintech innovator providing next-generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, ...

Geriatrics and Aging. 2009;12(1):48-52. Transdermal fentanyl may be used for patients who do not tolerate the orally available opioids or who cannot swallow sustained-release formulations.

A new class of synthetic opioids called nitazenes, which could be more potent than fentanyl, is being found around the world, including in the United States. Claire Zagorski, a harm reduction ...